Transplant Genomics Inc. — Form D
Transplant Genomics Inc. of Mansfield, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-09-06. The offering totals $8.0M, of which $8.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2018-09-06
- Form: D
- Accession: 0001749115-18-000003
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $8.0M
- Investors: 31
- Date of first sale: 2018-08-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-320736
Issuer
- Name: Transplant Genomics Inc.
- CIK: 0001604710
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 905 S. Main Street, Mansfield, MA, 02048
- Phone: 508-337-6200
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Michael Abecassis | Director | Mansfield, MA |
| David Kravitz | Director | Mansfield, MA |
| Chris O'Connor | Director | Vancouver, A1 |
| Stanley Rose | Director | Mansfield, MA |
| Jay Venkatesan | Director | Boston, MA |
| Roy First | Executive Officer | Mansfield, MA |
| Darren Lee | Executive Officer | Mansfield, MA |
| Peter Lewis | Executive Officer | Vancouver, A1 |
| Stanley Rose | Executive Officer | Mansfield, MA |
| Brett Jensen | Executive Officer | Providence, UT |
| Dierdre Pierry | Executive Officer | Brookline, MA |
| Kyle Hart | Executive Officer | Brookline, MA |
| Daniel Salomon | Director | Brookline, MA |
| Daniel Solomon | Director | Brookline, MA |
Other filings by this issuer (9)
More